Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Transpek IndustryBOM:506687 +5.08%69 EBITDA Margin % is 14.84% as of Mar. 2026, which is 22% below its 10-year median of 18.99. GuruFocus rates BOM:506687 with a GF Score™ of 69/100 and a GF Value™ of ₹1,529.58 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,577 Chemicals companies, Transpek Industry ranks better than 78.88% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Transpek Industry's EBITDA for the
three
months ended in Mar. 2026 was ₹220 Mil. Transpek Industry's Revenue for the
three
months ended in Mar. 2026 was ₹1,482 Mil. Therefore, Transpek Industry's EBITDA margin for the quarter that ended in Mar. 2026 was 14.84%.
Transpek Industry (BOM:506687) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Transpek Industry EBITDA Margin % Related Terms
Transpek Industry EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Transpek Industry's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Transpek Industry's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Transpek Industry EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Transpek Industry's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Transpek Industry's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Transpek Industry (BOM:506687) has a EBITDA Margin % of 14.84% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Transpek Industry and its competitors. This is 22% below median its historical median of 18.99. Over the past decade, Transpek Industry's EBITDA Margin % has ranged from 15.05 to 23.44. According to the industry distribution chart, Transpek Industry ranks #333 out of 1577 companies in the Chemicals industry, placing it in the top 21.1%.
Is Transpek Industry's EBITDA Margin % too high?
Transpek Industry's current EBITDA Margin % of 14.84% is 22% below median its 10-year median of 18.99. Over the past 10 years, this metric has ranged from a low of 15.05 to a high of 23.44. The Chemicals industry median EBITDA Margin % is 9.67. Transpek Industry's value of 14.84% is 53.5% above this industry median. Based on the distribution chart, Transpek Industry ranks #333 out of 1577 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Transpek Industry has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Transpek Industry's EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, Transpek Industry ranks #333 out of 1577 companies for EBITDA Margin %. This places Transpek Industry in the top 21% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.67. Transpek Industry's value of 14.84% is 53.5% above this benchmark. Historically, Transpek Industry's own EBITDA Margin % has ranged from 15.05 to 23.44 over the past decade. While the company's 10-year median is 18.99 vs. the industry median of 9.67, Transpek Industry has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.67, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Transpek Industry's current EBITDA Margin % of 14.84% is 53.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Transpek Industry and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Transpek Industry's current EBITDA Margin % is 14.84%, which is 22% below median its own 10-year median of 18.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transpek Industry stock overvalued right now?
Based on GuruFocus' analysis, Transpek Industry (BOM:506687) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,529.58, compared to a current price of ₹1,094.50 — trading 28.4% below its estimated fair value. The current EBITDA Margin % is 14.84%, which is 22% below median its 10-year median of 18.99 and 53.5% above the Chemicals industry median of 9.67. Transpek Industry's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Transpek Industry (BOM:506687), the current EBITDA Margin % is 14.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Transpek Industry (BOM:506687) Overvalued in 2026?
Based on GuruFocus' analysis, Transpek Industry stock appears to be undervalued.
The current stock price of ₹1,094.50 is trading 28.4% below its estimated GF Value™ of ₹1,529.58.
GuruFocus considers Transpek Industry to be Modestly Undervalued.
Key valuation signals for BOM:506687:
EBITDA Margin %: 14.84% (22% below median its 10-year median of 18.99)
GF Value™: ₹1,529.58 vs. price of ₹1,094.50 (28.4% below fair value)
Industry Position: 53.5% above the Chemicals median (#333 of 1577)
No single metric tells the full story. See the BOM:506687 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Transpek Industry Ltd is a chemical manufacturing company which engages in the manufacturing and export of a range of Chemicals; Pesticides; Organic compounds. The Company is engaged in the business of manufacturing of Chemicals which is the only operating Segment. These products are used in various industrial applications, such as polymers, plastics, performance materials, agrochemicals, pharmaceuticals, and Other Applications. The group sells its products in India and also exports to other countries, of which key revenue is derived from North America.
69GF Score
Get the complete analysis for BOM:506687
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:506687 has been successfully added to your 
